Here are six observations:
1. The global market will likely exceed $2.5 billion by 2026.
2. In 2017, the market was worth $771.6 million.
3. The market will witness growth due to the rising number of cervical disc degenerative disorder cases.
4. The metal over biocompatible material type segment will likely dominate the market due to its clinical benefits and clinical trial support.
5. North America, followed by Europe, will continue to lead the market space.
6. AxioMed, DePuy Synthes, FH Orthopaedics, Globus Medical, Medicrea, Medtronic Sofamor Danek, NuVasive, Osimplant, Pioneer Surgical, Ranier Technology, Spinal Kinetics, Spinal Motion and Stryker represent key market players.
More articles on devices:
Spinal implants market to experience 5.5% CAGR through 2023: 3 observations
How Mizuho OSI® will stay on the forefront of orthopedic innovation
Mazor Robotics vs. SeaSpine: Who grossed $131M in revenues?
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
